Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Nagel

Showing results (91-100 of 92) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 92 results.
Journal of Neurology|March 25, 2025
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2Joyce Christin Rittel, Dominica Hudasch, Kathrin Doppler, et al.
Brain : a Journal of Neurology|March 8, 2022
Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 diseaseThomas Grüter, Franziska E Möllers, Anja Tietz, et al.
Pageof 10

Showing results (91-100 of 92) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 92 results.
Journal of Neurology|March 25, 2025
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2Joyce Christin Rittel, Dominica Hudasch, Kathrin Doppler, et al.
Brain : a Journal of Neurology|March 8, 2022
Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 diseaseThomas Grüter, Franziska E Möllers, Anja Tietz, et al.
Pageof 10